nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—NISCH—hypertension	0.156	0.371	CbGaD
Oxymetazoline—ADRA2B—hypertension	0.0727	0.173	CbGaD
Oxymetazoline—HTR2B—hypertension	0.06	0.143	CbGaD
Oxymetazoline—NISCH—Guanabenz—hypertension	0.0551	0.122	CbGbCtD
Oxymetazoline—NISCH—Guanfacine—hypertension	0.0512	0.113	CbGbCtD
Oxymetazoline—ADRA1A—hypertension	0.045	0.107	CbGaD
Oxymetazoline—HTR1B—hypertension	0.036	0.0857	CbGaD
Oxymetazoline—ADRA2A—hypertension	0.0318	0.0758	CbGaD
Oxymetazoline—NISCH—Clonidine—hypertension	0.025	0.0554	CbGbCtD
Oxymetazoline—HTR2A—hypertension	0.0187	0.0445	CbGaD
Oxymetazoline—HTR1B—Pindolol—hypertension	0.013	0.0287	CbGbCtD
Oxymetazoline—ADRA2C—Guanabenz—hypertension	0.0127	0.028	CbGbCtD
Oxymetazoline—ADRA1D—Terazosin—hypertension	0.0122	0.027	CbGbCtD
Oxymetazoline—ADRA2B—Guanabenz—hypertension	0.012	0.0266	CbGbCtD
Oxymetazoline—ADRA2B—Guanfacine—hypertension	0.0112	0.0247	CbGbCtD
Oxymetazoline—ADRA1D—Fenoldopam—hypertension	0.011	0.0244	CbGbCtD
Oxymetazoline—HTR1B—Penbutolol—hypertension	0.0106	0.0234	CbGbCtD
Oxymetazoline—ADRA1D—Doxazosin—hypertension	0.0102	0.0225	CbGbCtD
Oxymetazoline—ADRA2C—Fenoldopam—hypertension	0.01	0.0222	CbGbCtD
Oxymetazoline—ADRA2B—Fenoldopam—hypertension	0.00949	0.021	CbGbCtD
Oxymetazoline—ADRA2A—Methyldopa—hypertension	0.00913	0.0202	CbGbCtD
Oxymetazoline—ADRA1B—Terazosin—hypertension	0.00887	0.0196	CbGbCtD
Oxymetazoline—HTR1D—Prazosin—hypertension	0.00871	0.0193	CbGbCtD
Oxymetazoline—ADRA1D—Prazosin—hypertension	0.00835	0.0185	CbGbCtD
Oxymetazoline—ADRA2A—Guanabenz—hypertension	0.00835	0.0185	CbGbCtD
Oxymetazoline—ADRA1B—Fenoldopam—hypertension	0.00802	0.0178	CbGbCtD
Oxymetazoline—ADRA2A—Guanfacine—hypertension	0.00776	0.0172	CbGbCtD
Oxymetazoline—ADRA1B—Doxazosin—hypertension	0.0074	0.0164	CbGbCtD
Oxymetazoline—ADRA1D—Nicardipine—hypertension	0.00721	0.016	CbGbCtD
Oxymetazoline—ADRA1D—Carvedilol—hypertension	0.00721	0.016	CbGbCtD
Oxymetazoline—ADRA2B—Prazosin—hypertension	0.00719	0.0159	CbGbCtD
Oxymetazoline—ADRA1A—Terazosin—hypertension	0.007	0.0155	CbGbCtD
Oxymetazoline—HTR1B—Propranolol—hypertension	0.00663	0.0147	CbGbCtD
Oxymetazoline—ADRA2A—Fenoldopam—hypertension	0.0066	0.0146	CbGbCtD
Oxymetazoline—ADRA2C—Carvedilol—hypertension	0.00655	0.0145	CbGbCtD
Oxymetazoline—ADRA1D—Clonidine—hypertension	0.00633	0.014	CbGbCtD
Oxymetazoline—ADRA1A—Fenoldopam—hypertension	0.00633	0.014	CbGbCtD
Oxymetazoline—ADRA2B—Carvedilol—hypertension	0.00621	0.0138	CbGbCtD
Oxymetazoline—ADRA2A—Doxazosin—hypertension	0.00609	0.0135	CbGbCtD
Oxymetazoline—ADRA1B—Prazosin—hypertension	0.00608	0.0135	CbGbCtD
Oxymetazoline—ADRA1B—vas deferens—hypertension	0.00586	0.174	CbGeAlD
Oxymetazoline—ADRA1A—Doxazosin—hypertension	0.00584	0.0129	CbGbCtD
Oxymetazoline—ADRA2C—Clonidine—hypertension	0.00575	0.0127	CbGbCtD
Oxymetazoline—ADRA2B—Clonidine—hypertension	0.00545	0.0121	CbGbCtD
Oxymetazoline—ADRA1B—Nicardipine—hypertension	0.00525	0.0116	CbGbCtD
Oxymetazoline—ADRA1B—Carvedilol—hypertension	0.00525	0.0116	CbGbCtD
Oxymetazoline—ADRA2A—Prazosin—hypertension	0.005	0.0111	CbGbCtD
Oxymetazoline—ADRA1A—Prazosin—hypertension	0.0048	0.0106	CbGbCtD
Oxymetazoline—ADRA1B—Clonidine—hypertension	0.00461	0.0102	CbGbCtD
Oxymetazoline—ADRA2A—Carvedilol—hypertension	0.00432	0.00956	CbGbCtD
Oxymetazoline—ADRA1A—Carvedilol—hypertension	0.00414	0.00917	CbGbCtD
Oxymetazoline—ADRA1A—Nicardipine—hypertension	0.00414	0.00917	CbGbCtD
Oxymetazoline—ADRA2A—Clonidine—hypertension	0.00379	0.0084	CbGbCtD
Oxymetazoline—ADRA1A—Clonidine—hypertension	0.00363	0.00805	CbGbCtD
Oxymetazoline—HTR2A—arteriole—hypertension	0.00152	0.0449	CbGeAlD
Oxymetazoline—HTR2A—locus ceruleus—hypertension	0.00122	0.0362	CbGeAlD
Oxymetazoline—Xylometazoline—ADRA2B—hypertension	0.00113	0.392	CrCbGaD
Oxymetazoline—HTR2A—pulmonary artery—hypertension	0.000994	0.0294	CbGeAlD
Oxymetazoline—HTR2A—sympathetic nervous system—hypertension	0.000966	0.0286	CbGeAlD
Oxymetazoline—HTR2A—vagus nerve—hypertension	0.000936	0.0277	CbGeAlD
Oxymetazoline—HTR2A—vein—hypertension	0.000904	0.0268	CbGeAlD
Oxymetazoline—HTR1B—artery—hypertension	0.000766	0.0227	CbGeAlD
Oxymetazoline—HTR1D—artery—hypertension	0.000741	0.022	CbGeAlD
Oxymetazoline—Xylometazoline—ADRA1A—hypertension	0.000696	0.243	CrCbGaD
Oxymetazoline—HTR1E—brainstem—hypertension	0.00069	0.0204	CbGeAlD
Oxymetazoline—HTR2A—autonomic nervous system—hypertension	0.00065	0.0192	CbGeAlD
Oxymetazoline—NISCH—myocardium—hypertension	0.000627	0.0186	CbGeAlD
Oxymetazoline—HTR2A—hindlimb—hypertension	0.000601	0.0178	CbGeAlD
Oxymetazoline—HTR1B—blood vessel—hypertension	0.000597	0.0177	CbGeAlD
Oxymetazoline—HTR1D—blood vessel—hypertension	0.000578	0.0171	CbGeAlD
Oxymetazoline—Xylometazoline—HTR1B—hypertension	0.000557	0.194	CrCbGaD
Oxymetazoline—HTR2A—urine—hypertension	0.000529	0.0157	CbGeAlD
Oxymetazoline—Xylometazoline—ADRA2A—hypertension	0.000493	0.172	CrCbGaD
Oxymetazoline—NISCH—nephron tubule—hypertension	0.00046	0.0136	CbGeAlD
Oxymetazoline—NISCH—adrenal cortex—hypertension	0.000453	0.0134	CbGeAlD
Oxymetazoline—NISCH—heart—hypertension	0.000438	0.013	CbGeAlD
Oxymetazoline—NISCH—smooth muscle tissue—hypertension	0.000434	0.0129	CbGeAlD
Oxymetazoline—NISCH—decidua—hypertension	0.000426	0.0126	CbGeAlD
Oxymetazoline—NISCH—cortex of kidney—hypertension	0.000394	0.0117	CbGeAlD
Oxymetazoline—HTR2A—artery—hypertension	0.000368	0.0109	CbGeAlD
Oxymetazoline—NISCH—medulla oblongata—hypertension	0.000353	0.0105	CbGeAlD
Oxymetazoline—HTR1E—central nervous system—hypertension	0.000348	0.0103	CbGeAlD
Oxymetazoline—ADRA1B—kidney—hypertension	0.000345	0.0102	CbGeAlD
Oxymetazoline—NISCH—adrenal gland—hypertension	0.000327	0.00968	CbGeAlD
Oxymetazoline—HTR1B—brainstem—hypertension	0.000326	0.00966	CbGeAlD
Oxymetazoline—HTR1D—brainstem—hypertension	0.000316	0.00936	CbGeAlD
Oxymetazoline—HTR2C—brainstem—hypertension	0.000313	0.00927	CbGeAlD
Oxymetazoline—HTR2A—endothelium—hypertension	0.000311	0.00922	CbGeAlD
Oxymetazoline—ADRA2C—cardiac ventricle—hypertension	0.000305	0.00902	CbGeAlD
Oxymetazoline—HTR2A—blood vessel—hypertension	0.000287	0.0085	CbGeAlD
Oxymetazoline—ADRA2C—myocardium—hypertension	0.000286	0.00849	CbGeAlD
Oxymetazoline—HTR1B—cardiovascular system—hypertension	0.000266	0.00789	CbGeAlD
Oxymetazoline—HTR2B—adrenal cortex—hypertension	0.000263	0.00778	CbGeAlD
Oxymetazoline—HTR1D—cardiovascular system—hypertension	0.000258	0.00764	CbGeAlD
Oxymetazoline—HTR2B—heart—hypertension	0.000254	0.00753	CbGeAlD
Oxymetazoline—HTR1D—kidney—hypertension	0.000252	0.00747	CbGeAlD
Oxymetazoline—HTR2B—smooth muscle tissue—hypertension	0.000252	0.00747	CbGeAlD
Oxymetazoline—HTR2B—decidua—hypertension	0.000247	0.00732	CbGeAlD
Oxymetazoline—ADRA1A—brainstem—hypertension	0.000243	0.00719	CbGeAlD
Oxymetazoline—HTR2B—cardiovascular system—hypertension	0.00024	0.0071	CbGeAlD
Oxymetazoline—ADRA1D—endocrine gland—hypertension	0.000236	0.00701	CbGeAlD
Oxymetazoline—HTR2B—cortex of kidney—hypertension	0.000228	0.00677	CbGeAlD
Oxymetazoline—HTR2C—medulla oblongata—hypertension	0.000218	0.00646	CbGeAlD
Oxymetazoline—ADRA1B—central nervous system—hypertension	0.000218	0.00645	CbGeAlD
Oxymetazoline—ADRA1D—central nervous system—hypertension	0.000213	0.00631	CbGeAlD
Oxymetazoline—ADRA2C—nephron tubule—hypertension	0.00021	0.00622	CbGeAlD
Oxymetazoline—ADRA1A—heart—hypertension	0.00021	0.00622	CbGeAlD
Oxymetazoline—ADRA2C—adrenal cortex—hypertension	0.000207	0.00613	CbGeAlD
Oxymetazoline—ADRA2C—heart—hypertension	0.0002	0.00592	CbGeAlD
Oxymetazoline—ADRA1A—cardiovascular system—hypertension	0.000198	0.00587	CbGeAlD
Oxymetazoline—ADRA2C—decidua—hypertension	0.000194	0.00576	CbGeAlD
Oxymetazoline—HTR2B—adrenal gland—hypertension	0.00019	0.00562	CbGeAlD
Oxymetazoline—ADRA2C—kidney—hypertension	0.000185	0.00547	CbGeAlD
Oxymetazoline—HTR1B—endocrine gland—hypertension	0.000183	0.00541	CbGeAlD
Oxymetazoline—ADRA2C—cortex of kidney—hypertension	0.00018	0.00533	CbGeAlD
Oxymetazoline—ADRA2C—cardiac atrium—hypertension	0.000171	0.00507	CbGeAlD
Oxymetazoline—HTR1B—central nervous system—hypertension	0.000165	0.00487	CbGeAlD
Oxymetazoline—ADRA2C—medulla oblongata—hypertension	0.000161	0.00478	CbGeAlD
Oxymetazoline—ADRA2A—heart—hypertension	0.00016	0.00473	CbGeAlD
Oxymetazoline—HTR1D—central nervous system—hypertension	0.000159	0.00472	CbGeAlD
Oxymetazoline—HTR2C—central nervous system—hypertension	0.000158	0.00467	CbGeAlD
Oxymetazoline—HTR2A—brainstem—hypertension	0.000157	0.00465	CbGeAlD
Oxymetazoline—ADRA1A—adrenal gland—hypertension	0.000157	0.00464	CbGeAlD
Oxymetazoline—ADRA2A—decidua—hypertension	0.000155	0.0046	CbGeAlD
Oxymetazoline—ADRA2C—adrenal gland—hypertension	0.000149	0.00442	CbGeAlD
Oxymetazoline—HTR2B—central nervous system—hypertension	0.000148	0.00439	CbGeAlD
Oxymetazoline—ADRA2A—cortex of kidney—hypertension	0.000143	0.00425	CbGeAlD
Oxymetazoline—ADRA2A—cardiac atrium—hypertension	0.000136	0.00404	CbGeAlD
Oxymetazoline—ADRA1A—endocrine gland—hypertension	0.000136	0.00402	CbGeAlD
Oxymetazoline—HTR2A—heart—hypertension	0.000136	0.00402	CbGeAlD
Oxymetazoline—HTR2A—smooth muscle tissue—hypertension	0.000135	0.00399	CbGeAlD
Oxymetazoline—ADRA2A—medulla oblongata—hypertension	0.000129	0.00381	CbGeAlD
Oxymetazoline—HTR2A—cardiovascular system—hypertension	0.000128	0.00379	CbGeAlD
Oxymetazoline—HTR2A—kidney—hypertension	0.000125	0.00371	CbGeAlD
Oxymetazoline—ADRA1A—central nervous system—hypertension	0.000122	0.00363	CbGeAlD
Oxymetazoline—ADRA2A—adrenal gland—hypertension	0.000119	0.00353	CbGeAlD
Oxymetazoline—ADRA2C—central nervous system—hypertension	0.000117	0.00346	CbGeAlD
Oxymetazoline—HTR2A—medulla oblongata—hypertension	0.000109	0.00324	CbGeAlD
Oxymetazoline—ADRA2A—endocrine gland—hypertension	0.000103	0.00306	CbGeAlD
Oxymetazoline—HTR2A—adrenal gland—hypertension	0.000101	0.003	CbGeAlD
Oxymetazoline—ADRA2A—central nervous system—hypertension	9.3e-05	0.00276	CbGeAlD
Oxymetazoline—HTR2A—endocrine gland—hypertension	8.78e-05	0.0026	CbGeAlD
Oxymetazoline—HTR2A—central nervous system—hypertension	7.91e-05	0.00234	CbGeAlD
Oxymetazoline—ADRA2B—Signaling Pathways—NOS3—hypertension	8.94e-07	9.7e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3R1—hypertension	8.94e-07	9.7e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KDR—hypertension	8.87e-07	9.63e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MAPK8—hypertension	8.84e-07	9.6e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—AKT1—hypertension	8.82e-07	9.57e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EP300—hypertension	8.8e-07	9.55e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CXCL8—hypertension	8.79e-07	9.54e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SERPINE1—hypertension	8.75e-07	9.5e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—FGF2—hypertension	8.71e-07	9.45e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RHOA—hypertension	8.68e-07	9.42e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EP300—hypertension	8.62e-07	9.35e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SERPINE1—hypertension	8.61e-07	9.35e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3R1—hypertension	8.59e-07	9.32e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NOS3—hypertension	8.59e-07	9.32e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SRC—hypertension	8.56e-07	9.29e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—POMC—hypertension	8.55e-07	9.28e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MMP9—hypertension	8.54e-07	9.27e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PRKCB—hypertension	8.54e-07	9.27e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FN1—hypertension	8.54e-07	9.27e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—F2—hypertension	8.54e-07	9.27e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CDKN1A—hypertension	8.51e-07	9.24e-06	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL6—hypertension	8.51e-07	9.23e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—INS—hypertension	8.5e-07	9.23e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PTEN—hypertension	8.49e-07	9.21e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AKT1—hypertension	8.49e-07	9.21e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ALB—hypertension	8.48e-07	9.21e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—FGF2—hypertension	8.47e-07	9.19e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RHOA—hypertension	8.44e-07	9.16e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RELA—hypertension	8.42e-07	9.14e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SRC—hypertension	8.38e-07	9.1e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—POMC—hypertension	8.37e-07	9.09e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCL2—hypertension	8.37e-07	9.08e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOTCH1—hypertension	8.36e-07	9.07e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL6—hypertension	8.35e-07	9.07e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3R1—hypertension	8.35e-07	9.07e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NOS3—hypertension	8.35e-07	9.07e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VEGFA—hypertension	8.34e-07	9.05e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—FGF2—hypertension	8.34e-07	9.05e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—INS—hypertension	8.33e-07	9.04e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RHOA—hypertension	8.31e-07	9.01e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MAPK8—hypertension	8.31e-07	9.01e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AKT1—hypertension	8.28e-07	8.99e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MTOR—hypertension	8.25e-07	8.96e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IGF1—hypertension	8.22e-07	8.93e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NOS3—hypertension	8.22e-07	8.92e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3R1—hypertension	8.22e-07	8.92e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT2—hypertension	8.22e-07	8.92e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCL2—hypertension	8.19e-07	8.89e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—hypertension	8.18e-07	8.88e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—hypertension	8.16e-07	8.86e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3R1—hypertension	8.11e-07	8.81e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—NOS3—hypertension	8.11e-07	8.81e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EP300—hypertension	8.1e-07	8.79e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RELA—hypertension	8.08e-07	8.77e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IGF1—hypertension	8.05e-07	8.74e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT2—hypertension	8.05e-07	8.73e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—hypertension	8.01e-07	8.7e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTEN—hypertension	7.97e-07	8.65e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MMP9—hypertension	7.95e-07	8.62e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CXCL8—hypertension	7.93e-07	8.61e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MTOR—hypertension	7.93e-07	8.6e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CDKN1A—hypertension	7.92e-07	8.59e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PTEN—hypertension	7.9e-07	8.57e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SRC—hypertension	7.87e-07	8.55e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RELA—hypertension	7.86e-07	8.53e-06	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKT1—hypertension	7.85e-07	8.52e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SERPINE1—hypertension	7.81e-07	8.48e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—POMC—hypertension	7.78e-07	8.44e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RELA—hypertension	7.74e-07	8.4e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—INS—hypertension	7.74e-07	8.4e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MAPK8—hypertension	7.73e-07	8.39e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MTOR—hypertension	7.71e-07	8.37e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKT1—hypertension	7.71e-07	8.36e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MYC—hypertension	7.67e-07	8.33e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—hypertension	7.67e-07	8.32e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKT1—hypertension	7.66e-07	8.32e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TGFB1—hypertension	7.65e-07	8.31e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SERPINE1—hypertension	7.65e-07	8.3e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CXCL8—hypertension	7.62e-07	8.27e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCL2—hypertension	7.61e-07	8.26e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—EP300—hypertension	7.6e-07	8.25e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MTOR—hypertension	7.59e-07	8.24e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—FGF2—hypertension	7.56e-07	8.21e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL6—hypertension	7.54e-07	8.19e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RHOA—hypertension	7.53e-07	8.18e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EP300—hypertension	7.53e-07	8.18e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MYC—hypertension	7.51e-07	8.15e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—hypertension	7.5e-07	8.14e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TGFB1—hypertension	7.49e-07	8.13e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IGF1—hypertension	7.48e-07	8.12e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT2—hypertension	7.48e-07	8.12e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3R1—hypertension	7.46e-07	8.09e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NOS3—hypertension	7.46e-07	8.09e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—hypertension	7.45e-07	8.08e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—hypertension	7.42e-07	8.05e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CXCL8—hypertension	7.41e-07	8.04e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—FGF2—hypertension	7.4e-07	8.04e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RHOA—hypertension	7.38e-07	8.01e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—hypertension	7.36e-07	7.99e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—hypertension	7.35e-07	7.97e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SRC—hypertension	7.33e-07	7.95e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOS3—hypertension	7.3e-07	7.92e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3R1—hypertension	7.3e-07	7.92e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CXCL8—hypertension	7.29e-07	7.91e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—hypertension	7.24e-07	7.86e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—hypertension	7.17e-07	7.79e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—hypertension	7.16e-07	7.77e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CDKN1A—hypertension	7.15e-07	7.76e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—hypertension	7.14e-07	7.74e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTEN—hypertension	7.13e-07	7.74e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SERPINE1—hypertension	7.11e-07	7.71e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MYC—hypertension	7.06e-07	7.66e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—hypertension	7.05e-07	7.65e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—hypertension	7.04e-07	7.65e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TGFB1—hypertension	7.04e-07	7.64e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RELA—hypertension	7.02e-07	7.62e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MAPK8—hypertension	6.98e-07	7.57e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—hypertension	6.96e-07	7.55e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—hypertension	6.93e-07	7.53e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—hypertension	6.9e-07	7.49e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—hypertension	6.89e-07	7.48e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MTOR—hypertension	6.88e-07	7.47e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FGF2—hypertension	6.88e-07	7.47e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RELA—hypertension	6.87e-07	7.46e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CDKN1A—hypertension	6.87e-07	7.45e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RHOA—hypertension	6.85e-07	7.44e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTEN—hypertension	6.85e-07	7.43e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EP300—hypertension	6.8e-07	7.38e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3R1—hypertension	6.78e-07	7.36e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOS3—hypertension	6.78e-07	7.36e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MTOR—hypertension	6.74e-07	7.32e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—hypertension	6.7e-07	7.27e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MAPK8—hypertension	6.7e-07	7.27e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—hypertension	6.68e-07	7.25e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CDKN1A—hypertension	6.68e-07	7.25e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTEN—hypertension	6.66e-07	7.23e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CXCL8—hypertension	6.61e-07	7.18e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SRC—hypertension	6.61e-07	7.18e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—hypertension	6.6e-07	7.16e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CDKN1A—hypertension	6.57e-07	7.13e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MYC—hypertension	6.57e-07	7.13e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTEN—hypertension	6.56e-07	7.12e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TGFB1—hypertension	6.55e-07	7.11e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EP300—hypertension	6.53e-07	7.09e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MAPK8—hypertension	6.52e-07	7.07e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—hypertension	6.5e-07	7.05e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CXCL8—hypertension	6.48e-07	7.03e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTEN—hypertension	6.47e-07	7.02e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—hypertension	6.44e-07	6.99e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—hypertension	6.42e-07	6.97e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MAPK8—hypertension	6.41e-07	6.96e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—hypertension	6.4e-07	6.94e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—hypertension	6.39e-07	6.94e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RELA—hypertension	6.39e-07	6.93e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EP300—hypertension	6.35e-07	6.9e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SRC—hypertension	6.35e-07	6.89e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—hypertension	6.3e-07	6.84e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—hypertension	6.29e-07	6.83e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MTOR—hypertension	6.26e-07	6.8e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—hypertension	6.26e-07	6.79e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EP300—hypertension	6.25e-07	6.79e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—hypertension	6.19e-07	6.71e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SRC—hypertension	6.18e-07	6.71e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—EP300—hypertension	6.17e-07	6.7e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—hypertension	6.17e-07	6.69e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—hypertension	6.16e-07	6.68e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SRC—hypertension	6.08e-07	6.6e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CXCL8—hypertension	6.02e-07	6.53e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—hypertension	6.02e-07	6.53e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—hypertension	5.98e-07	6.49e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CDKN1A—hypertension	5.96e-07	6.47e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTEN—hypertension	5.95e-07	6.46e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MYC—hypertension	5.93e-07	6.43e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—hypertension	5.92e-07	6.43e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TGFB1—hypertension	5.91e-07	6.42e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—hypertension	5.86e-07	6.36e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CDKN1A—hypertension	5.84e-07	6.34e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTEN—hypertension	5.82e-07	6.32e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MAPK8—hypertension	5.82e-07	6.32e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—hypertension	5.81e-07	6.31e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—hypertension	5.8e-07	6.3e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—hypertension	5.8e-07	6.29e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—hypertension	5.79e-07	6.29e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—hypertension	5.77e-07	6.26e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—hypertension	5.72e-07	6.21e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MAPK8—hypertension	5.7e-07	6.18e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MYC—hypertension	5.69e-07	6.18e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—hypertension	5.68e-07	6.17e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TGFB1—hypertension	5.68e-07	6.16e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EP300—hypertension	5.67e-07	6.16e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—hypertension	5.65e-07	6.13e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—hypertension	5.57e-07	6.04e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EP300—hypertension	5.55e-07	6.03e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MYC—hypertension	5.54e-07	6.01e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TGFB1—hypertension	5.52e-07	5.99e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SRC—hypertension	5.52e-07	5.99e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MYC—hypertension	5.45e-07	5.91e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—hypertension	5.44e-07	5.91e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TGFB1—hypertension	5.44e-07	5.9e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDKN1A—hypertension	5.42e-07	5.89e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—hypertension	5.42e-07	5.88e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTEN—hypertension	5.41e-07	5.87e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SRC—hypertension	5.4e-07	5.86e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—hypertension	5.39e-07	5.85e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—hypertension	5.37e-07	5.83e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—hypertension	5.33e-07	5.78e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—hypertension	5.32e-07	5.77e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—hypertension	5.3e-07	5.76e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MAPK8—hypertension	5.29e-07	5.75e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—hypertension	5.28e-07	5.73e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—hypertension	5.26e-07	5.71e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—hypertension	5.21e-07	5.65e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EP300—hypertension	5.16e-07	5.6e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SRC—hypertension	5.02e-07	5.45e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MYC—hypertension	4.94e-07	5.36e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—hypertension	4.93e-07	5.36e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TGFB1—hypertension	4.93e-07	5.35e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—hypertension	4.89e-07	5.31e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—hypertension	4.89e-07	5.3e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—hypertension	4.87e-07	5.28e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MYC—hypertension	4.84e-07	5.25e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—hypertension	4.83e-07	5.25e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TGFB1—hypertension	4.83e-07	5.24e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—hypertension	4.73e-07	5.14e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—hypertension	4.67e-07	5.07e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—hypertension	4.59e-07	4.98e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—hypertension	4.55e-07	4.94e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—hypertension	4.55e-07	4.93e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MYC—hypertension	4.5e-07	4.88e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TGFB1—hypertension	4.49e-07	4.87e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—hypertension	4.47e-07	4.86e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—hypertension	4.46e-07	4.84e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—hypertension	4.4e-07	4.77e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—hypertension	4.28e-07	4.64e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—hypertension	4.16e-07	4.52e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—hypertension	4.11e-07	4.46e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—hypertension	4.1e-07	4.45e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—hypertension	4.06e-07	4.41e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—hypertension	3.97e-07	4.31e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—hypertension	3.95e-07	4.28e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—hypertension	3.84e-07	4.17e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—hypertension	3.78e-07	4.1e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—hypertension	3.73e-07	4.05e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—hypertension	3.72e-07	4.03e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—hypertension	3.69e-07	4.01e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—hypertension	3.64e-07	3.95e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—hypertension	3.43e-07	3.72e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—hypertension	3.38e-07	3.67e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—hypertension	3.36e-07	3.64e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—hypertension	3.12e-07	3.38e-06	CbGpPWpGaD
